journal
MENU ▼
Read by QxMD icon Read
search

European Journal of Clinical Pharmacology

journal
https://www.readbyqxmd.com/read/28343258/variation-of-antibiotic-consumption-and-its-correlated-factors-in-turkey
#1
Ayfer Sahin, Ahmet Akici, Volkan Aydin, Bahar Melik, Mesil Aksoy, Ali Alkan
BACKGROUND: Presentation of antibiotic utilization data by reliable and comparable analyses constitutes an important way of ensuring rational use of antibiotics. This study aimed to evaluate antibiotic consumption (AC) of Turkey by each city/region and to investigate any association of such consumption with socio-economic factors. METHOD: For 81 provinces and 12 regions in Turkey, AC data from IMS (Intercontinental Medical Statistics) in 2011 was analyzed in accordance with "ATC/DDD, DID" (Anatomical Therapeutic Chemical/Defined Daily Doses, DID = DDD/1000 inhabitants/day) methodology supported by World Health Organization...
March 25, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28326435/tapering-or-abrupt-cessation-of-proton-pump-inhibitors
#2
LETTER
Emily Reeve, Sarah Hilmer
No abstract text is available yet for this article.
March 22, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28314882/a-global-view-of-undergraduate-education-in-pharmacovigilance
#3
Jenny Hartman, Linda Härmark, Eugène van Puijenbroek
PURPOSE: The aim of this study was to gain insight in current pharmacovigilance educational activities and to gather information on which topics should be included in the undergraduate pharmacovigilance core curriculum. METHOD: A web-based questionnaire was carried out containing 45 questions divided over four sections between 28 October 2014 and 31 January 2015. Potential participants working in pharmacovigilance and/or providing training in this field were invited via email and a widespread web link and snowball sampling was used to recruit additional participants...
March 17, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28299402/comparative-analysis-of-three-drug-drug-interaction-screening-systems-against-probable-clinically-relevant-drug-drug-interactions-a-prospective-cohort-study
#4
Neža Muhič, Ales Mrhar, Miran Brvar
PURPOSE: Drug-drug interaction (DDI) screening systems report potential DDIs. This study aimed to find the prevalence of probable DDI-related adverse drug reactions (ADRs) and compare the clinical usefulness of different DDI screening systems to prevent or warn against these ADRs. METHODS: A prospective cohort study was conducted in patients urgently admitted to medical departments. Potential DDIs were checked using Complete Drug Interaction®, Lexicomp® Online™, and Drug Interaction Checker®...
March 15, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28293714/dose-related-effect-of-statins-in-patients-with-endovascular-coiling-or-microsurgical-clipping-for-aneurysmal-subarachnoid-hemorrhage-updated-study-level-meta-analysis
#5
Kyu-Sun Choi, Jae Min Kim, Hyeong-Joong Yi, Seon-Heui Lee, Taeho Lim, Wonhee Kim, Youngsuk Cho, Jin-Hwan Cheong
PURPOSE: We aimed to quantitatively assess the effects of short-term statin use on delayed ischemic neurologic deficits (DINDs) and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage (SAH) through a meta-analysis of the available evidence. METHODS: We searched the electronic databases up to April 8, 2016 to retrieve relevant studies comparing the outcomes between immediate statin-treated in statin-naïve patients and untreated patients following aneurysmal SAH...
March 14, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28283692/pharmacokinetics-and-pharmacogenetics-of-the-mek1-2-inhibitor-selumetinib-in-asian-and-western-healthy-subjects-a-pooled-analysis
#6
Angela W Dymond, Cathy Elks, Paul Martin, David J Carlile, Gabriella Mariani, Susan Lovick, Yifan Huang, Ulrike Lorch, Helen Brown, Karen So
PURPOSE: Emerging data on selumetinib, a MEK1/2 inhibitor in clinical development, suggest a possible difference in pharmacokinetics (PK) between Japanese and Western patients. This pooled analysis sought to assess the effect of ethnicity on selumetinib exposure in healthy Western and Asian subjects, and to identify any association between genetic variants in the UGT1A1, CYP2C19 and ABCG2 genes and observed differences in selumetinib PK. METHODS: A pooled analysis of data from ten Phase I studies, one in Asian subjects (encompassing Japanese, non-Japanese Asian and Indian Asian subjects) and nine in Western subjects, was conducted...
March 10, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280892/antidepressant-pharmacotherapy-in-old-age-depression-a-review-and-clinical-approach
#7
REVIEW
Nathalie Pruckner, Vjera Holthoff-Detto
PURPOSE: Depression in old age is a disabling disease associated with functional and cognitive decline severely affecting quality of life. Studies specifically investigating antidepressant treatment for this special cohort of patients remain scarce and results are often conflicting. A narrative literature review was undertaken, synthesizing findings from published studies, systematic reviews, and treatment guidelines specifically conducted in elderly depressed patients to summarize implications and current recommendations as well as gaps in evidence for old-age pharmacologic treatment...
March 10, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280891/number-of-medications-and-adverse-drug-events-by-unintentional-poisoning-among-older-adults-in-consideration-of-inappropriate-drug-use-a-swedish-population-based-matched-case-control-study
#8
Christian Rausch, L Laflamme, U Bültmann, J Möller
PURPOSE: This national, population-based study aims to determine the association between the number of prescribed medications and adverse drug events (ADE) by unintentional poisoning and examine this risk when known indicators of inappropriate drug use (IDU) are accounted for. METHODS: We employed a matched case-control design among people living in Sweden who were 50 years and older. Cases experiencing an ADE by unintentional poisoning resulting in hospitalization or death (n = 5336) were extracted from the National Health and Death Registers from January 2006 to December 2009...
March 9, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280890/utilization-of-chi-square-statistics-for-screening-adverse-drug-drug-interactions-in-spontaneous-reporting-systems
#9
Masahiko Gosho, Kazushi Maruo, Keisuke Tada, Akihiro Hirakawa
PURPOSE: We proposed a statistical criterion to detect drug-drug interactions causing adverse drug reactions in spontaneous reporting systems. METHODS: The used criterion quantitatively measures the discrepancy between the observed and expected number of adverse events via chi-square statistics. We compared the performance of our method with that of Norén et al. (Stat Med 2008; 27 (16): 3057-3070) through a simulation study. RESULTS: When the number of events for a combination of two drugs was equal to or lower than two, the false positive rate for our method ranged from 0...
March 9, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280889/end-points-in-heart-failure-are-we-doing-it-right
#10
REVIEW
Luxitaa Goenka, Melvin George, Sandhiya Selvarajan
PURPOSE: Heart Failure (HF) continues to be associated with high mortality and morbidity. We attempted to identify the most common end points used in phase 3 clinical trials of heart failure and discuss their merits and demerits. METHODS: Literature evaluation was done using the databases PubMed and Clinicaltrials.gov from January 2010 to December 2016 to identify randomised clinical trials (RCTs) evaluating the effect of therapeutic drugs on heart failure. Following the literature search, the data on the primary end points were extracted from each of the selected trials...
March 9, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280888/respiratory-depression-related-to-multiple-drug-drug-interactions-precipitated-by-a-fluconazole-loading-dose-in-a-patient-treated-with-oxycodone
#11
LETTER
Bruno Charpiat, Michel Tod, Benjamin Darnis, Guillaume Boulay, Marie-Claude Gagnieu, Jean-Yves Mabrut
No abstract text is available yet for this article.
March 9, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28280887/brivaracetam-population-pharmacokinetics-in-children-with-epilepsy-aged-1%C3%A2-month-to-16%C3%A2-years
#12
Rik Schoemaker, Janet R Wade, Armel Stockis
PURPOSE: The aims of the study were to develop a population pharmacokinetic model of orally administered brivaracetam in paediatric patients and to provide dosing suggestions. METHODS: Analysis included 600 brivaracetam plasma concentrations from a phase 2a study (NCT00422422; N01263) in 96 paediatric patients with epilepsy aged 1 month to 16 years, taking one to three concomitant antiepileptic drugs (AEDs). Pharmacokinetic analysis was performed using non-linear mixed effects modelling, and a stepwise covariate search was used to determine factors influencing brivaracetam clearance...
March 9, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28271239/phase-i-trial-to-investigate-the-effect-of-renal-impairment-on-isavuconazole-pharmacokinetics
#13
Robert W Townsend, Shahzad Akhtar, Harry Alcorn, Jolene K Berg, Donna L Kowalski, Salim Mujais, Amit V Desai
PURPOSE: The purpose of the study is to evaluate the effect of renal impairment (RI) and end-stage renal disease (ESRD) on the pharmacokinetics (PK) of isavuconazole and the inactive cleavage product, BAL8728. METHODS: A single intravenous dose of the prodrug isavuconazonium sulfate (372 mg, equivalent to 200 mg isavuconazole and 75 mg of BAL8728 cleavage product) was administered to healthy controls (parts 1 and 2) and participants with mild, moderate, or severe RI (part 2) or ESRD (part 1); ESRD participants received two doses of 200 mg isavuconazole, 1 h post-dialysis (day 1) and prior to dialysis (day 15)...
March 7, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28265691/safety-pharmacokinetics-and-pharmacodynamics-of-bms-986142-a-novel-reversible-btk-inhibitor-in-healthy-participants
#14
Sun Ku Lee, Jun Xing, Ian M Catlett, Robert Adamczyk, Amber Griffies, Ang Liu, Bindu Murthy, Miroslawa Nowak
PURPOSE: BMS-986142 is an oral, small-molecule reversible inhibitor of Bruton's tyrosine kinase. The main objectives of our phase I studies were to characterize the safety and tolerability, pharmacokinetics, and pharmacodynamics of BMS-986142 in healthy participants, and to investigate the potential for the effect of BMS-986142 on the PK of methotrexate (MTX) in combination. METHODS: In a combined single ascending dose and multiple ascending dose study, the safety, pharmacokinetics, and pharmacodynamics of BMS-986142 were assessed in healthy non-Japanese participants following administration of a single dose (5-900 mg) or multiple doses (25-350 mg, once daily for 14 days)...
March 6, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28265690/the-impact-of-gastrectomy-on-the-pharmacokinetics-of-atazanavir-and-tenofovir
#15
LETTER
Cristina Gervasoni, Dario Cattaneo, Chiara Resnati, Diletta Pezzani, Agostino Riva
No abstract text is available yet for this article.
March 6, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28258356/the-role-of-initial-clinical-presentation-comorbidity-and-treatment-in-multiple-myeloma-patients-on-survival-a-detailed-population-based-cohort-study
#16
B E Oortgiesen, E N van Roon, P Joosten, R E Kibbelaar, H Storm, S Hovenga, B van Rees, G Woolthuis, N Veeger, E G de Waal, M Hoogendoorn
PURPOSE: This prospective, observational population-based cohort study was performed to determine overall survival (OS) in multiple myeloma (MM) patients in Friesland, the Netherlands, in the era of novel agents and to analyse the influence of first-line treatment, MM-related end-organ damage and comorbidities at initial presentation on OS. METHODS: Detailed clinical information was obtained from the population-based registry 'HemoBase' during the period January 2005 to January 2013, with a follow-up to January 2014...
March 3, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28251277/hospital-admissions-due-to-adverse-drug-reactions-in-the-elderly-a-meta-analysis
#17
T J Oscanoa, F Lizaraso, Alfonso Carvajal
INTRODUCTION: It is currently admitted that adverse drug reactions (ADRs) account for a great burden of disease. Of particular concern are ADR-induced hospital admissions, particularly in the elderly; they receive most of the medications and they are the most prone to develop ADRs. Therefore, our aim was to carry out a study of ADR-induced hospital admissions focused on the elderly population. METHODS: For the purpose, a systematic review and meta-analysis was performed of those studies addressing ADR-induced hospital admissions in patients over 60 years of age...
March 1, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28251276/lack-of-essential-information-in-spontaneous-reports-of-adverse-drug-reactions-in-catalonia-a-restraint-to-the-potentiality-for-signal-detection
#18
Lorraine Plessis, Ainhoa Gómez, Núria García, Gloria Cereza, Albert Figueras
PURPOSE: The aim of this study is to analyze the quality of the information contained in the adverse drug reactions (ADR) reports and to describe the magnitude and characteristics of the lacking information. METHODS: All reports of serious ADR received by the Catalan Center of Pharmacovigilance in 2014 were analyzed using the VigiGrade and a more clinical and qualitative approach. RESULTS: Up to 824 reports describing serious ADR were included in the study; of them, 503 (61...
March 1, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28246889/an-evaluation-of-the-prevalence-of-potentially-inappropriate-medications-in-older-people-with-cognitive-impairment-living-in-northern-sweden-using-the-eu-7-pim-list
#19
Eva Sönnerstam, Maria Sjölander, Maria Gustafsson
PURPOSE: As people get older, their sensitivity to drugs and adverse drug reactions can increase due to pharmacokinetic and pharmacodynamic changes. Older people with dementia are a particularly vulnerable group of people. They are at an increased risk of being prescribed potentially inappropriate medications, which may lead to harmful consequences. The aim of this study was to investigate the prevalence of potentially inappropriate medications among older patients with cognitive impairment...
March 1, 2017: European Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/28246888/the-effects-of-2%C3%A2-weeks-of-statin-treatment-on-mitochondrial-respiratory-capacity-in-middle-aged-males-the-lifestat-study
#20
Magnus Asping, Nis Stride, Ditte Søgaard, Tine Lovsø Dohlmann, Jørn W Helge, Flemming Dela, Steen Larsen
BACKGROUND: Statins are used to lower cholesterol in plasma and are one of the most used drugs in the world. Many statin users experience muscle pain, but the mechanisms are unknown at the moment. Many studies have hypothesized that mitochondrial function could be involved in these side effects. AIM: The aim of the study was to investigate mitochondrial function after 2 weeks of treatment with simvastatin (S; n = 10) or pravastatin (P; n = 10) in healthy middle-aged participants...
February 28, 2017: European Journal of Clinical Pharmacology
journal
journal
25237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"